The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Muscle disorder 4
SANDOSTATIN LAR DEPOT Muscle fatigue 4
SANDOSTATIN LAR DEPOT Nail disorder 4
SANDOSTATIN LAR DEPOT Nasal discomfort 4
SANDOSTATIN LAR DEPOT Nasal obstruction 4
SANDOSTATIN LAR DEPOT Ocular discomfort 4
SANDOSTATIN LAR DEPOT Ocular icterus 4
SANDOSTATIN LAR DEPOT Off label use 4
SANDOSTATIN LAR DEPOT Orthostatic hypotension 4
SANDOSTATIN LAR DEPOT Overweight 4
SANDOSTATIN LAR DEPOT Pancreatitis 4
SANDOSTATIN LAR DEPOT Pelvic fracture 4
SANDOSTATIN LAR DEPOT Post procedural haemorrhage 4
SANDOSTATIN LAR DEPOT Puncture site induration 4
SANDOSTATIN LAR DEPOT Purulence 4
SANDOSTATIN LAR DEPOT Rales 4
SANDOSTATIN LAR DEPOT Rectal prolapse 4
SANDOSTATIN LAR DEPOT Respiratory distress 4
SANDOSTATIN LAR DEPOT Respiratory rate decreased 4
SANDOSTATIN LAR DEPOT Rheumatoid arthritis 4

Total Records: 2,045     Number of Pages: 103